Vitamin Shoppe Inc (VSI) Receives Consensus Rating of “Hold” from Analysts

Shares of Vitamin Shoppe Inc (NYSE:VSI) have earned an average recommendation of “Hold” from the ten research firms that are covering the company, Marketbeat Ratings reports. Four research analysts have rated the stock with a sell recommendation, four have issued a hold recommendation and one has given a buy recommendation to the company. The average twelve-month price target among brokers that have issued ratings on the stock in the last year is $4.95.

Several brokerages have issued reports on VSI. Morgan Stanley lowered their target price on shares of Vitamin Shoppe from $4.00 to $3.75 and set an “equal weight” rating on the stock in a research note on Wednesday, February 28th. Zacks Investment Research raised shares of Vitamin Shoppe from a “strong sell” rating to a “hold” rating in a research note on Sunday, January 21st. Finally, ValuEngine cut shares of Vitamin Shoppe from a “buy” rating to a “hold” rating in a research note on Sunday, December 31st.

How to Become a New Pot Stock Millionaire

Shares of VSI stock traded down $0.05 during midday trading on Friday, reaching $3.90. 329,909 shares of the company traded hands, compared to its average volume of 589,710. The stock has a market cap of $95.60, a price-to-earnings ratio of -0.36 and a beta of 0.64. The company has a debt-to-equity ratio of 0.65, a quick ratio of 0.36 and a current ratio of 2.25. Vitamin Shoppe has a 12 month low of $2.95 and a 12 month high of $20.70.

Vitamin Shoppe (NYSE:VSI) last announced its earnings results on Tuesday, February 27th. The specialty retailer reported ($0.17) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.20) by $0.03. Vitamin Shoppe had a negative net margin of 21.39% and a positive return on equity of 3.13%. The company had revenue of $268.77 million for the quarter, compared to analysts’ expectations of $269.24 million. During the same quarter in the previous year, the company posted $0.36 EPS. The firm’s quarterly revenue was down 11.8% on a year-over-year basis. research analysts predict that Vitamin Shoppe will post -0.19 EPS for the current fiscal year.

In other news, major shareholder Vintage Capital Management Llc purchased 234,343 shares of the stock in a transaction dated Friday, December 29th. The shares were purchased at an average price of $4.36 per share, with a total value of $1,021,735.48. The acquisition was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, major shareholder Shah Capital Management purchased 300,000 shares of the stock in a transaction dated Monday, February 5th. The shares were purchased at an average cost of $3.83 per share, for a total transaction of $1,149,000.00. The disclosure for this purchase can be found here. In the last ninety days, insiders have acquired 1,000,639 shares of company stock worth $4,387,647. 1.07% of the stock is currently owned by corporate insiders.

Several hedge funds have recently made changes to their positions in the company. Macquarie Group Ltd. boosted its position in shares of Vitamin Shoppe by 180.2% during the 4th quarter. Macquarie Group Ltd. now owns 52,681 shares of the specialty retailer’s stock valued at $232,000 after acquiring an additional 33,881 shares during the last quarter. Stone Ridge Asset Management LLC acquired a new position in shares of Vitamin Shoppe during the 4th quarter valued at about $285,000. Guggenheim Capital LLC boosted its position in shares of Vitamin Shoppe by 136.5% during the 4th quarter. Guggenheim Capital LLC now owns 244,781 shares of the specialty retailer’s stock valued at $1,077,000 after acquiring an additional 141,281 shares during the last quarter. Landscape Capital Management L.L.C. raised its holdings in Vitamin Shoppe by 341.5% in the 4th quarter. Landscape Capital Management L.L.C. now owns 474,790 shares of the specialty retailer’s stock valued at $2,089,000 after buying an additional 367,240 shares during the period. Finally, Lazard Asset Management LLC purchased a new stake in Vitamin Shoppe in the 4th quarter valued at about $115,000. 89.03% of the stock is currently owned by hedge funds and other institutional investors.

ILLEGAL ACTIVITY NOTICE: This report was first published by Ticker Report and is the property of of Ticker Report. If you are viewing this report on another domain, it was illegally copied and reposted in violation of United States & international copyright legislation. The legal version of this report can be viewed at https://www.tickerreport.com/banking-finance/3297250/vitamin-shoppe-inc-vsi-receives-consensus-rating-of-hold-from-analysts.html.

About Vitamin Shoppe

Vitamin Shoppe, Inc (VSI) is a multi-channel specialty retailer and contract manufacturer of vitamins, minerals, herbs, specialty supplements, sports nutrition, and other health and wellness products. The Company operates through three segments: retail, direct and manufacturing. The retail segment includes Vitamin Shoppe, Super Supplements and Vitapath retail store formats.

Analyst Recommendations for Vitamin Shoppe (NYSE:VSI)

Receive News & Ratings for Vitamin Shoppe Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vitamin Shoppe and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Astro 24-Hour Volume Reaches $3,638.00
Astro 24-Hour Volume Reaches $3,638.00
SyncFab Hits One Day Trading Volume of $45,979.00
SyncFab Hits One Day Trading Volume of $45,979.00
Microsoft Co.  Expected to Post Quarterly Sales of $25.71 Billion
Microsoft Co. Expected to Post Quarterly Sales of $25.71 Billion
Zacks: Analysts Anticipate Shutterstock  Will Announce Quarterly Sales of $150.17 Million
Zacks: Analysts Anticipate Shutterstock Will Announce Quarterly Sales of $150.17 Million
$8.32 Billion in Sales Expected for Enterprise Products  This Quarter
$8.32 Billion in Sales Expected for Enterprise Products This Quarter
Akamai Technologies  Expected to Post Quarterly Sales of $654.02 Million
Akamai Technologies Expected to Post Quarterly Sales of $654.02 Million


© 2006-2018 Ticker Report. Google+.